The purpose of this protocol is to examine the efficacy and toxicity of intra-arterial fluorodeoxyuridine (FUDR) and oral leucovorin using a modified hepatic artery catheter in combination with system administration of 5-fluorouracil (5FU) and alpha interferon for patients with colon cancer metastatic to the liver. Intra-arterial infusion of FUDR using standard catheters produces a high response rate but is associated with significant hepatic toxicity. The major complication of intra-arterial infusion are accidental extra-hepatic delivery of chemotherapy, chemical hepatitis, chemical cholecystitis and a potentially lethal complication of biliary sclerosis. A modified hepatic artery catheter has been developed that produces turbulence as a result of the inflation of a balloon at the catheter tip. The balloon hepatic artery catheter produces turbulence and allows mixing of the infusate with blood and may prevent complications associated with the currently employed catheters. Extrahepatic progression of metastatis colon cancer is the other problem associated with hepatic artery infusion therapy. A very effective chemoimmunotherapy regimen consisting of 5FU and alpha interferon will be combined with intra-arterial FUDR in an attempt to control metastasis disease outside of the liver. Although responses were seen, catheter malfunction and catheter-related complications remain a significant problem.
Showing the most recent 10 out of 22 publications
